Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
132 Results Found
AHA Value Initiative Members In Action: Northern Maine Medical Center – Fort Kent, Maine
Northern Maine Medical Center – Fort Kent, Maine
Purchase of Retail Pharmacy Enhances Services to the Community
AHA’s Feedback on the Public Meeting, “Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions
AHA provides feedback on the Food and Drug Administration’s request for comments on the public meeting, “Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions.
AHA Comments on HHS' Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs
AHA comments on the Department of Health and Human Services’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
AHA comments on DEA’s proposed rule on controlled substances quotas
We concur with the DEA that setting quotas for the production of opioid medications can be an effective step in “preventing the accumulation of controlled substances in amounts exceeding legitimate
Group letter re: DEA’s proposed rule on controlled substances quotas
The undersigned groups thank the Drug Enforcement Administration (DEA) for the opportunity to comment on its proposed rule regarding controlled substances quotas.
AHA, Others Urge DEA to Help Ease Shortage of Injectable Opioids
The AHA, American Society of Health-System Pharmacists, American Society of Anesthesiologists, Institute for Safe Medication Practices, and American Society of Clinical Oncology today urged the Drug Enforcement Administration to temporarily adjust the aggregate production quotas for certain injectable opioid medications.
'Take Back Day' Saturday to safely dispose of prescription drugs
Oct. 27 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired prescription pills at sites throughout the country.
FDA guidance aims to increase generic competition for topical drugs
The Food and Drug Administration yesterday released a series of guidance documents intended to help manufacturers develop generic transdermal and topical delivery systems, products that deliver a drug through a patient’s skin.
FDA issues revised guidance for outsourcing facilities that compound drugs
The Food and Drug Administration yesterday released revised draft guidance for facilities that compound human drugs as outsourcing facilities.
AHA recommends legislative, regulatory actions to address drug shortages
The AHA today submitted to the Food and Drug Administration legislative, regulatory and best practice recommendations to address new and chronic prescription drug shortages that threaten the quality of patient care and increase hospital and health system costs.